Literature DB >> 3899035

Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, and clinical outcome.

V Drelichman, J D Band.   

Abstract

From 1974 to 1982, 38 patients developed Citrobacter bacteremia at two adult community-teaching hospitals in the Detroit Medical Center (incidence, 1.2 cases per 10,000 discharges). Citrobacter accounted for 0.7% of all bacteremias during the study period. Of 31 cases reviewed, Citrobacter bacteremia frequently developed in elderly patients (65%) and was hospital acquired (77%). Initial sites of infection included the urinary tract (39%), gastrointestinal tract (27%), wound (10%), and unknown (13%). More bacteremias caused by Citrobacter diversus tended to arise from the urinary tract, while patients with Citrobacter freundii bacteremia had significantly more gallbladder disease. Patients with Citrobacter bacteremia were more likely than patients with Escherichia coli bacteremia to have had additional pathogens in the bloodstream, to develop bacteremia in the hospital, and to have undergone invasive procedures contributing to infection. Significant differences were not observed in demographic, host, or other epidemiologic or clinical factors examined. Of patients with Citrobacter bacteremia, 48% died.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899035

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  31 in total

1.  An ascending aortic mass infected with Citrobacter koseri in a young woman.

Authors:  Deacon Lee; Rebecca Godfrey; Jonathan Hyde; Rachael James
Journal:  Clin Med (Lond)       Date:  2019-11-08       Impact factor: 2.659

2.  Citrobacter koseri folliculitis of the face.

Authors:  D D Raia; M Barbareschi; S Veraldi
Journal:  Infection       Date:  2015-01-29       Impact factor: 3.553

Review 3.  Musculoskeletal infections associated with Citrobacter koseri.

Authors:  T A Kwaees; Z Hakim; C Weerasinghe; P Dunkow
Journal:  Ann R Coll Surg Engl       Date:  2016-07-14       Impact factor: 1.891

4.  Low-virulence Citrobacter species encode resistance to multiple antimicrobials.

Authors:  C Pepperell; J V Kus; M A Gardam; A Humar; L L Burrows
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

5.  Fatal Citrobacter farmeri meningitis in a patient with nasopharyngeal cancer.

Authors:  Che-Kim Tan; Chih-Cheng Lai; Sheng-Hsiang Lin; Chun-Hsing Liao; Yu-Tsung Huang; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

6.  Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients.

Authors:  Peter W Kim; Anthony D Harris; Mary-Claire Roghmann; J Glenn Morris; Arjun Strinivasan; Eli N Perencevich
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

7.  Bacterial translocation in the rat model of lectin induced diarrhoea.

Authors:  R Shoda; D Mahalanabis; M A Wahed; M J Albert
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

Review 8.  Bifocal cervical spondylodiscitis due to Citrobacter diversus.

Authors:  A Sotto; J C Bernard; C Brunschwig; D Blin; F M Lopez; B Combe
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

9.  Citrobacter infections in a general hospital: characteristics and outcomes.

Authors:  G Samonis; D E Karageorgopoulos; D P Kofteridis; D K Matthaiou; V Sidiropoulou; S Maraki; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-06       Impact factor: 3.267

10.  Infective endocarditis due to Citrobacter koseri in an immunocompetent adult.

Authors:  A Dzeing-Ella; T A Szwebel; J Loubinoux; S Coignard; A Bouvet; C Le Jeunne; E Aslangul
Journal:  J Clin Microbiol       Date:  2009-10-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.